Literature DB >> 14732709

Suppression of Staphylococcal Enterotoxin B-induced Toxicity by a Nuclear Import Inhibitor.

Danya Liu1, Xue Yan Liu, Daniel Robinson, Christie Burnett, Charity Jackson, Louis Seele, Ruth Ann Veach, Sheila Downs, Robert D Collins, Dean W Ballard, Jacek Hawiger.   

Abstract

Staphylococcal enterotoxin B and related toxins that target T cells have the capacity to elicit systemic inflammation, tissue injury, and death. Genes that encode mediators of inflammation can be globally inhibited by blocking the nuclear import of stress-responsive transcription factors. Here we show that cell-permeant peptides targeting Rch1/importin alpha/karyopherin alpha 2, a nuclear import adaptor protein, are delivered to T cells where they inhibit the staphylococcal enterotoxin B-induced production of inflammatory cytokines ex vivo in cultured primary spleen cells and in vivo. The systemic production of tumor necrosis factor alpha, interferon gamma, and interleukin-6 was attenuated in mice either by a cell-permeant cyclized form of SN50 peptide or by a transgene whose product suppresses the nuclear import of transcription factor nuclear factor kappa B in T cells. The extent of liver apoptosis and hemorrhagic necrosis was also reduced, which correlated with significantly decreased mortality rates. These findings highlight nuclear import inhibitors as a potentially useful countermeasure for staphylococcal enterotoxin B and other toxins that trigger harmful systemic inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14732709     DOI: 10.1074/jbc.M313442200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Antitumor activity of cell-permeable p18(INK4c) with enhanced membrane and tissue penetration.

Authors:  Junghee Lim; Jungeun Kim; Tam Duong; Guewha Lee; Junghee Kim; Jina Yoon; Jaetaek Kim; Hyuncheol Kim; H Earl Ruley; Wael El-Rifai; Daewoong Jo
Journal:  Mol Ther       Date:  2012-05-22       Impact factor: 11.454

2.  Antitumor activity of cell-permeable RUNX3 protein in gastric cancer cells.

Authors:  Junghee Lim; Tam Duong; Nga Do; Phuong Do; Jaetaek Kim; Hyuncheol Kim; Wael El-Rifai; H Earl Ruley; Daewoong Jo
Journal:  Clin Cancer Res       Date:  2012-12-10       Impact factor: 12.531

3.  A nuclear import inhibitory peptide ameliorates the severity of cholecystokinin-induced acute pancreatitis.

Authors:  Tamas Letoha; Csaba Somlai; Tamas Takacs; Annamaria Szabolcs; Katalin Jarmay; Zoltan Rakonczay; Peter Hegyi; Ilona Varga; Jozsef Kaszaki; Istvan Krizbai; Imre Boros; Erno Duda; Erzsebet Kusz; Botond Penke
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

4.  In vivo islet protection by a nuclear import inhibitor in a mouse model of type 1 diabetes.

Authors:  Daniel J Moore; Jozef Zienkiewicz; Peggy L Kendall; Danya Liu; Xueyan Liu; Ruth Ann Veach; Robert D Collins; Jacek Hawiger
Journal:  PLoS One       Date:  2010-10-06       Impact factor: 3.240

5.  Intracellular delivery of a cell-penetrating SOCS1 that targets IFN-gamma signaling.

Authors:  Antonio DiGiandomenico; Lukasz S Wylezinski; Jacek Hawiger
Journal:  Sci Signal       Date:  2009-07-21       Impact factor: 8.192

6.  Myocyte remodeling in response to hypertrophic stimuli requires nucleocytoplasmic shuttling of muscle LIM protein.

Authors:  Samuel Y Boateng; Samuel E Senyo; Lixin Qi; Paul H Goldspink; Brenda Russell
Journal:  J Mol Cell Cardiol       Date:  2009-04-17       Impact factor: 5.000

7.  Suppression of acute lung inflammation by intracellular peptide delivery of a nuclear import inhibitor.

Authors:  Danya Liu; Jozef Zienkiewicz; Antonio DiGiandomenico; Jacek Hawiger
Journal:  Mol Ther       Date:  2009-03-03       Impact factor: 11.454

Review 8.  Therapeutic down-modulators of staphylococcal superantigen-induced inflammation and toxic shock.

Authors:  Teresa Krakauer
Journal:  Toxins (Basel)       Date:  2010-07-29       Impact factor: 4.546

9.  Lethality in a murine model of pulmonary anthrax is reduced by combining nuclear transport modifier with antimicrobial therapy.

Authors:  Ruth Ann Veach; Jozef Zienkiewicz; Robert D Collins; Jacek Hawiger
Journal:  PLoS One       Date:  2012-01-26       Impact factor: 3.240

Review 10.  PI3K/Akt/mTOR, a pathway less recognized for staphylococcal superantigen-induced toxicity.

Authors:  Teresa Krakauer
Journal:  Toxins (Basel)       Date:  2012-11-15       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.